Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Reporting of Harms in Randomized Controlled Trials Published in Urology Journals: An Updated Analysis.
The Journal of Urology ( IF 6.6 ) Pub Date : 2023-12-08 , DOI: 10.1097/ju.0000000000003740 Reece M. Anderson 1 , Andriana Peña 1 , Trevor Magee 1 , Del Perkins 1 , Bradley S. Johnson 2, 3 , Rodney H. Breau 4 , Matt Vassar 1, 5
The Journal of Urology ( IF 6.6 ) Pub Date : 2023-12-08 , DOI: 10.1097/ju.0000000000003740 Reece M. Anderson 1 , Andriana Peña 1 , Trevor Magee 1 , Del Perkins 1 , Bradley S. Johnson 2, 3 , Rodney H. Breau 4 , Matt Vassar 1, 5
Affiliation
Harms are often overlooked, but important, outcomes of randomized controlled trial reporting. Our goal was to determine if harms reporting has improved in high-impact urology journals.
中文翻译:
泌尿学期刊上发表的随机对照试验中的危害报告:更新的分析。
随机对照试验报告的结果常常被忽视,但却很重要。我们的目标是确定高影响力泌尿学期刊的危害报告是否有所改善。
更新日期:2023-12-08
中文翻译:
泌尿学期刊上发表的随机对照试验中的危害报告:更新的分析。
随机对照试验报告的结果常常被忽视,但却很重要。我们的目标是确定高影响力泌尿学期刊的危害报告是否有所改善。